| Date |
Announcements
|
Attachment |
| Nov 30, 2007 |
ATC demonstrates activity against emerging class resistance |
 PDF file - 64.31 KB
|
| Nov 20, 2007 |
Chairman's Address AGM 2007 |
PDF file - 44.43 KB
|
| Nov 20, 2007 |
Avexa gets "green light" to progress ATC into Phase 111 |
PDF file - 116.4 KB
|
| Sep 4, 2007 |
Avexa announces positive results of ATC 24 week data |
PDF file - 68.97 KB
|
| Aug 9, 2007 |
AVX Audio Broadcast 9 August 2007 |
PDF file - 63.54 KB
|
| Aug 8, 2007 |
Appendix 4E |
PDF file - 518.66 KB
|
| Aug 8, 2007 |
Avexa positioned to launch Phase 111 Clinical Trial of ATC |
PDF file - 63.72 KB
|
| Jul 26, 2007 |
AVX Audio Broadcast July 2007 |
PDF file - 60.65 KB
|
| Jul 26, 2007 |
Avexa releases ATC Phase IIb Clinical Trial Update |
PDF file - 122.63 KB
|
| Jul 4, 2007 |
Apricitabine Clinical Trial Update |
PDF file - 55.63 KB
|
| Jun 8, 2007 |
New Director Joins Avexa Board |
PDF file - 60.06 KB
|
| May 30, 2007 |
Avexa Wins $4.3M Commercial Ready Grant |
PDF file - 66.35 KB
|
| May 1, 2007 |
Avexa Concludes Allocation following Rights Issue |
PDF file - 53.43 KB
|
| Apr 24, 2007 |
Avexa closes oversubscribed Rights Issue |
PDF file - 57.02 KB
|
| Apr 19, 2007 |
AVX Audio Broadcast |
PDF file - 58.12 KB
|
| Apr 18, 2007 |
Avexa secures CCR5 Inhibitor HIV program with TargetDrug |
PDF file - 65.86 KB
|
| Apr 3, 2007 |
ATC demonstrates broader range of activity against drug resistant HIV strains |
PDF file - 63.86 KB
|
| Mar 21, 2007 |
Boardroom Radio Broadcast |
PDF file - 52.94 KB
|
| Mar 21, 2007 |
Avexa announces $75 million for Phase 111 program |
PDF file - 69.01 KB
|
| Mar 19, 2007 |
Avexa reports positive Phase 11b result |
PDF file - 95.39 KB
|
| Mar 15, 2007 |
Avexa Announces Trading Halt |
PDF file - 43.3 KB
|
| Feb 22, 2007 |
Avexa reports substantial progress for apricitabine |
PDF file - 52.67 KB
|
| Feb 15, 2007 |
Avexa and Novasep announce signing of manufacturing agreement for ATC |
PDF file - 59.28 KB
|
| Jan 31, 2007 |
Avexa announces resignation of Dr Errol Malta Non-Executive Director |
PDF file - 50.79 KB
|
| Jan 8, 2007 |
Phase 1 trial shows ATC has potential for combination therapy with Tipranavir |
PDF file - 68.11 KB
|
Our attachments use Adobe PDF which means you may have to use an Acrobat Reader. You can
